We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
2D Catalytic, Chemodynamic, and Ferroptotic Vermiculite Nanomedicine.
- Authors
Ma, Lifang; Huang, Hui; Feng, Wei; Chen, Liang; Xia, Lili; Yu, Yongchun; Wang, Jiayi; Chen, Yu
- Abstract
The emerging chemodynamic therapy employs an iron‐based catalytic Fenton reaction to transform less‐reactive endogenous hydrogen peroxide within the tumor microenvironment (TME) into a highly toxic hydroxyl radical for killing cancer cells. However, the effective deployment of chemodynamic modality remains challenging, mired by a paucity of Fenton agents and overexpressed antioxidant glutathione (GSH) in cancer cells. Herein, a clay‐based 2D vermiculite nanosheet as a self‐reinforcing chemodynamic nanoagent for efficient lung cancer treatment is engineered. The engineered 2D vermiculite nanosheets are not only biocompatible with normal cells but also capable of regulating the TME through depleting GSH, which ameliorates the antioxidant activity of cancer cells. Meanwhile, GSH consumption results in increased intracellular reactive oxygen species content and enhanced lipid peroxidation level, thus inducing ferroptosis and augmenting chemodynamic cell‐killing efficacy. In particular, the ferrous oxidase hephaestin is the direct therapeutic target for 2D vermiculite nanosheets to fight against lung cancer cells. Systematic in vivo evaluations on a xenografted tumor model verify the favorable biosafety and effective tumor suppression capacity of the engineered 2D vermiculite nanosheets‐mediated chemodynamic tumor therapy by inducing desirable ferroptosis. Therefore, the developed vermiculite nanosheets represent the paradigm of 2D ferroptosis‐inducing nanomedicine for synergistic and efficient cancer treatment.
- Subjects
VERMICULITE; NANOMEDICINE; REACTIVE oxygen species; HYDROXYL group; HABER-Weiss reaction; HYDROGEN peroxide
- Publication
Advanced Functional Materials, 2022, Vol 32, Issue 51, p1
- ISSN
1616-301X
- Publication type
Article
- DOI
10.1002/adfm.202208220